Myocardial contractility after in vitro treatment with class III antiarrhythmic drug Nibentan

Myocardial contractility after in vitro treatment with class III antiarrhythmic drug Nibentan

Myocardial contractility was studied in vitro in response to treatment with class III antiarrhythmic drug Nibentan. The contractile response to Nibentan in increasing concentrations of 1.66, 2.5, and 3.5 mM was estimated on strips of animal myocardium and human right atrial auricle.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bulletin of experimental biology and medicine 2006-01, Vol.141 (1), p.81-83
Hauptverfasser: Latfullin, I A, Gaifullina, R F, Dzhordzhikiya, R K, Nigmatullina, R R
Format: Artikel
Sprache:eng
Schlagworte:
Animals
Anti-Arrhythmia Agents - pharmacology
Antiarrhythmics
Atrial Appendage - drug effects
Benzamides - pharmacology
Heart - drug effects
Humans
In Vitro Techniques
Male
Myocardial Contraction - drug effects
Rats
Rats, Wistar
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Myocardial contractility was studied in vitro in response to treatment with class III antiarrhythmic drug Nibentan. The contractile response to Nibentan in increasing concentrations of 1.66, 2.5, and 3.5 mM was estimated on strips of animal myocardium and human right atrial auricle.
ISSN:0007-4888
1573-8221
DOI:10.1007/s10517-006-0099-y